English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A procoagulant snake venom serine protease was isolated from the venom of the nose-horned viper ( Vipera ammodytes ammodytes ). This 34 kDa glycoprotein, termed Vaa SP-VX, possesses five kDa N-linked carbohydrates. Amino acid sequencing showed Vaa SP-VX to be a chymotrypsin-like serine protease. Structurally, it is highly homologous to Vaa SP-6 from the same venom and to nikobin from the venom of Vipera nikolskii , neither of which have known functions. Vaa SP-VX does not affect platelets. The specific proteolysis of blood coagulation factors X and V by VaaSP-VX suggests that its blood-coagulation-inducing effect is due to its ability to activate these two blood coagulation factors, which following activation, combine to form the prothrombinase complex. Vaa SP-VX may thus represent the first example of a serine protease with such a dual activity, which makes it a highly suitable candidate to replace diluted Russell's viper venom in lupus anticoagulant testing, thus achieving greater reliability of the analysis. As a blood-coagulation-promoting substance that is resistant to serpin inhibition, Vaa SP-VX is also interesting from the therapeutic point of view for treating patients suffering from hemophilia.

The Procoagulant Snake Venom Serine Protease Potentially Having a Dual, Blood Coagulation Factor V and X-Activating Activity